Sanda, Sahak A.
HRN: 28-24-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2025
MUPIROCIN 2%, 15G (TUBE)
12/16/2025
12/22/2025
TOPICAL
2%
TID
Non Healing Wound
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes